S. G. Afanasyev

Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study

Kohei Shitara, Sun Young Rha, Lucjan Wyrwicz et al. · The Lancet Oncology · 2023 · 339 citations

Medicine, Oncology, Pharmacology +16

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 278 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

LBA74 Pembrolizumab plus chemotherapy vs chemotherapy as neoadjuvant and adjuvant therapy in locally-advanced gastric and gastroesophageal junction cancer: The phase III KEYNOTE-585 study

Kohei Shitara, Sun Young Rha, Lucjan Wyrwicz et al. · Annals of Oncology · 2023 · 34 citations · Full text

Medicine, Oncology, Pharmacology +15

Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study

Sun Young Rha, Lucjan Wyrwicz, Nina Karaseva et al. · Journal of Clinical Oncology · 2025 · 29 citations

Medicine, Oncology, Perioperative Medicine +17

Isolation and characterization of exosomes from blood plasma of breast cancer and colorectal cancer patients

Svetlana Tamkovich, N. V. Yunusova, A. K. Somov et al. · Biomeditsinskaya Khimiya · 2017 · 23 citations

Medicine, Cell Biology, Oncology +12